Patents by Inventor Thomas Westman

Thomas Westman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240140921
    Abstract: There is provided an alkali metal salt of 4-chloro-N-[2-[(4-chlorophenyl)methyl]-3-oxo-1,2,4-thiadiazol-5-yl]benzamide and formulations thereof. This salt finds particular utility in the treatment or prevention of a disorder or condition ameliorated by the activation of AMPK.
    Type: Application
    Filed: May 15, 2023
    Publication date: May 2, 2024
    Applicant: Betagenon AB
    Inventors: Thomas EDLUND, Jacob WESTMAN
  • Publication number: 20240082222
    Abstract: This invention relates to a new method of activating 5? adenosine monophosphate-activated protein kinase (AMPK) to treat certain diseases and disorders using a salt of 4-chloro-N[2-[(4-chlorophenyl)methyl]-3-oxo-1,2,4-thiadiazol-5-yl]benzamide in a dose-efficient manner. Diseases that may be treated in this way include type-2 diabetes.
    Type: Application
    Filed: January 11, 2022
    Publication date: March 14, 2024
    Applicant: Betagenon AB
    Inventors: Thomas EDLUND, Jacob WESTMAN
  • Patent number: D544402
    Type: Grant
    Filed: April 6, 2005
    Date of Patent: June 12, 2007
    Assignee: Land Systems Hagglunds Aktiebolag
    Inventors: Thomas Westman, Tore Gustafsson